Companies · Other Health Care

Mitesco, Inc.

VERO BEACH · Other Health Care

Diligence memoA one-page analyst read on Mitesco, Inc. — recommendation, valuation, rhythm, risks.
$29.6M
Total raised · real
8
Rounds
0.0×
Latest step-up
Top 13%
Sector rank · raised
Series A
Latest stage · inferred · Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Mitesco, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.02× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Quiet
  • Last raise 17 mo ago; this sector typically re-raises about every 14 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Mitesco, Inc. is one of 5376 Other Health Care companies tracked from VERO BEACH. By capital raised it ranks in the upper tier (ahead of 88% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2025-01-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2013-05-30 Raised $3.6M (real) Modeled valuation $89M (est)Seed2013Seed · 2016-07-01 Raised $2.3M (real) Modeled valuation $56M (est)Seed2016Seed · 2021-03-25 Raised $3.0M (real) Modeled valuation $54M (est)Seed2021Seed · 2021-03-31 Raised $1.6M (real) Modeled valuation $28M (est)Seed2021Seed · 2021-10-18 Raised $2.0M (real) Modeled valuation $29M (est)Seed2021Seed · 2021-10-18 Raised $3.1M (real) Modeled valuation $44M (est)Seed2021Series A · 2024-11-12 Raised $14M (real) Modeled valuation $59M (est)Series A2024Series A · 2025-01-20 Raised $100K (real) Modeled valuation $394K (est)Series A2025+$2.3M+$3.0M+$1.6M+$2.0M+$3.1M+$14M+$100KCumulative $30M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.6M · 2013
Seed extension$2.3M · 2016
Seed extension$3.0M · 2021
Seed extension$1.6M · 2021
Seed extension$2.0M · 2021
Seed extension$3.1M · 2021
Series A$13.9M · 2024
Series A extension$100K · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$394K
Base estimate est.
$128K
Conservative case
$750K
Upside case
$455K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $88.6M · 2013-05-302013Seed · modeled $55.8M · 2016-07-01Seed · modeled $54.3M · 2021-03-25Seed · modeled $28.2M · 2021-03-31Seed · modeled $28.7M · 2021-10-18Seed · modeled $44.0M · 2021-10-18Series A · modeled $58.8M · 2024-11-12Series A · modeled $394K · 2025-01-202025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
1.4 yr
Elapsed time used
1.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$2.5M/yr
Capital velocity
13.1 yr
On record since
2013
First round
8
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 12× above median
This company$29.6M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.0× of median
This company$100K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$394K
Sector median$22.1M

Raised more than 88% of sector peers (real $). Modeled value above 2% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #81 of 83.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)HelloJoy, Inc. · Series A Raised $26.3M · modeled $55.0M (est)Maui Imaging, Inc. · Series A Raised $29.9M · modeled $51.0M (est)Celltrio, Inc. · Series A Raised $15.0M · modeled $50.8M (est)Medmo, Inc. · Series A Raised $31.7M · modeled $44.7M (est)Vertical Orthopaedics, Inc. · Series A Raised $16.7M · modeled $44.0M (est)AbriCare, Inc. · Series A Raised $15.0M · modeled $39.1M (est)WP Stillwater, LLC · Series A Raised $14.3M · modeled $38.1M (est)Sylke, Inc. · Series A Raised $15.9M · modeled $37.6M (est)Iridex Corp · Series A Raised $10.0M · modeled $37.2M (est)2GHealth Inc. · Series A Raised $17.5M · modeled $35.6M (est)Okc Alf 4, Llc · Series A Raised $8.9M · modeled $34.5M (est)HC Jones, Inc. · Series A Raised $14.1M · modeled $33.4M (est)Mitesco, Inc. (this company) Raised $29.6M · modeled $394K (est)Mitesco, Inc.
CompanyStageRaised · realValue · estvs peer med.
HelloJoy, Inc.Series A$26.3M$55.0M3.37×
Maui Imaging, Inc.Series A$29.9M$51.0M3.12×
Celltrio, Inc.Series A$15.0M$50.8M3.11×
Medmo, Inc.Series A$31.7M$44.7M2.74×
Vertical Orthopaedics, Inc.Series A$16.7M$44.0M2.69×
AbriCare, Inc.Series A$15.0M$39.1M2.39×
WP Stillwater, LLCSeries A$14.3M$38.1M2.33×
Sylke, Inc.Series A$15.9M$37.6M2.30×
Iridex CorpSeries A$10.0M$37.2M2.28×
2GHealth Inc.Series A$17.5M$35.6M2.18×
Okc Alf 4, LlcSeries A$8.9M$34.5M2.11×
HC Jones, Inc.Series A$14.1M$33.4M2.04×
Mitesco, Inc. this companySeries A$29.6M$394K0.02×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.6M2013-05-30$17.9M$88.6M85%
Seed$2.3M2016-07-01$11.3M$55.8M85%
Seed$3.0M2021-03-25$15.0M$54.3M90%
Seed$1.6M2021-03-31$7.8M$28.2M90%
Seed$2.0M2021-10-18$10.1M$28.7M90%
Seed$3.1M2021-10-18$15.5M$44.0M90%
Series A$13.9M2024-11-12$63.4M$58.8M90%
Series A$100K2025-01-20$455K$394K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.6M2013-05-30
    • First recorded raise — entered as Seed.
    • 35 investors on this round.
  2. Seed$2.3M2016-07-01
    • Raised again after 37 mo — slower than the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • Revenue band moved $0–$1M → $1M–$5M.
    • Switched to Rule 506(c) (was Rule 06).
  3. Seed$3.0M2021-03-25
    • Raised again after 57 mo — slower than the ~14 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
    • Revenue band moved $1M–$5M → No revenue.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 4 investors on this round.
  4. Seed$1.6M2021-03-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 45 investors on this round.
  5. Seed$2.0M2021-10-18
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 4 investors on this round.
  6. Seed$3.1M2021-10-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 9 investors on this round.
  7. Series A$13.9M2024-11-12
    • Raised again after 37 mo — slower than the ~14 mo sector norm.
    • Round 4.5× larger than the prior — scaling up.
    • 6 investors on this round.
  8. Series A$100K2025-01-20
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 139.5× smaller than the prior — bridge or down round.
    • 3 investors on this round.
Intelligence
2026 ~Q3
Modeled next raise · ~20mo cadence
$100K
Modeled next size est.range $100K$160K
0.0×
Last step-up
$2.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Mitchell22 other2024-11
Stephen Keaveney2 other2016-07
Terry B Anderton2 other2013-05
Joakim B Lindblom1 other2013-05
Les B Anderton1 other2013-05
Dana H Reed2013-05
Dr. Jordan Balencic2024-11
Faraz Jenny Naqvi2021-10
H. Faraz Ingrid Naqvi2021-10
H. Faraz J Naqvi2021-03
Ingrid Jenny Lindtrom2021-10
James Michael Driscoll2016-07
Jenny Ingrid Lindstrom2021-10
Juan Carlos Iturregui2021-03
Juan Ingrid Iturregui2021-10
Jude B Blake2013-05
Lawrence Diamond2021-03
Mack Leath2024-11
Nicole B Fernandez McGovern2013-05
Phillip Crone2016-07
Phillip J Keller2021-03
Phillip Keller2021-10
Richard H Davis2013-05
Ronald J Riewold2021-03
Registry & provenance

Mitesco, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
802257
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Trunity, Inc.Other TechnologyPre-Seed$2.4M$5.5Mnetwork3 shared operators
Spectra7 Microsystems Inc.Other TechnologySeries A$28.5M$5.7Mnetwork1 shared operator · same stage
Trendlines Group Ltd.Other Health CareSeries A$18.5M$1.2Msame sector · same stage
Rimidi, Inc.Other Health CareSeries A$18.2M$1.4Msame sector · same stage
OurPharma Holdings LLCOther Health CareSeries A$15.9M$824Ksame sector · same stage
Wellist, Inc.Other Health CareSeries A$12.8M$1.3Msame sector · same stage
Ice Services LLCRetailingSeries A$19.2M$11.9Mnetwork1 shared operator · same stage
Treasure Valley Hospital Limited PartnershipOther Health CareSeries A$10.9M$368Ksame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Mitra RxDx, Inc.Other Health CareSeries C$1.0B87%
NewVetCo, Inc.Other Health CareSeed$60.7M87%
Mitralign, Inc.Other Health CareSeries A$197.1M86%
ConsejoSano, Inc.Other Health CareSeries B$335.4M86%
CRES Holdings, Inc.Other Health CareSeries C$66.9M85%
TGHCo, Inc.Other Health CareSeries B$178.0M85%
MedNoxa, Inc.Other Health CarePre-Seed$3.1M85%
Infab HoldCo, Inc.Other Health CareSeries B$807.5M84%
Frequently asked
How much funding has Mitesco, Inc. raised?
Mitesco, Inc. has raised approximately $29.6M in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is Mitesco, Inc.'s estimated valuation?
Provath's modeled valuation for Mitesco, Inc. is approximately $394K (modeled range $128K–$750K). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Mitesco, Inc. at?
Mitesco, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Jan 20.
What does Mitesco, Inc. do and where is it based?
Mitesco, Inc. operates in the Other Health Care sector, based in VERO BEACH.
Explore related

See where Mitesco, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Mitesco, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.